Prevalence of Dural Sinus Thrombosis in Female Patients Presenting to Emergency Department

Main Article Content

Madiha Irfan
Muhammad Abas Khan
Muhammad Riaz
Ijaz ul Haque
Ishtiaq Ahmad
Aadil Farooq
Zeenat Iqbal

Abstract

Background: Dural sinus thrombosis is an uncommon but clinically important form of cerebral venous thrombosis that predominantly affects young women and may present with nonspecific emergency neurological symptoms. Objective: To determine the prevalence of imaging-confirmed dural sinus thrombosis among female patients presenting to the emergency department with symptoms suggestive of cerebral venous thrombosis and to describe associated clinical, risk-factor, and radiological patterns. Methods: This prospective observational study was conducted in the emergency department of Lady Reading Hospital, Peshawar, from March to August 2024. Female patients aged 18–50 years with suspected cerebral venous thrombosis were consecutively enrolled. Diagnosis was confirmed using magnetic resonance venography or computed tomography venography. Demographic data, presenting symptoms, risk factors, symptom duration, and radiological findings were analyzed using SPSS version 26. Results: Among 120 suspected cases, 28 were diagnosed with dural sinus thrombosis, giving a prevalence of 23.3%. The mean age was 29.84 ± 8.72 years. Headache was the most common symptom (80.0%), followed by vomiting (60.0%) and seizures (40.0%). Pregnancy or puerperium was the leading risk factor among confirmed cases (42.9%) and showed significant association with thrombosis (p = 0.02). Superior sagittal sinus involvement was most frequent (71.4%), and multiple sinus involvement occurred in 64.3%. Conclusion: Dural sinus thrombosis was a clinically meaningful finding among suspected female emergency presentations, especially in reproductive-age women with pregnancy-related risk exposure.

Article Details

Section

Articles

How to Cite

1.
Madiha Irfan, Muhammad Abas Khan, Muhammad Riaz, Ijaz ul Haque, Ishtiaq Ahmad, Aadil Farooq, et al. Prevalence of Dural Sinus Thrombosis in Female Patients Presenting to Emergency Department. JHWCR [Internet]. 2026 May 2 [cited 2026 May 3];4(9):1-7. Available from: https://www.jhwcr.com/index.php/jhwcr/article/view/1533

References

1. Ferro JM, Bousser MG, Canhão P, Coutinho JM, Crassard I, Dentali F, et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis. Eur Stroke J. 2020;5(3):219–234. doi:10.1177/2396987320920385.

2. Devasagayam S, Wyatt B, Leyden J, Kleinig T. Cerebral venous sinus thrombosis incidence is higher than previously thought. Stroke. 2020;51(2):e14–e16. doi:10.1161/STROKEAHA.119.028419.

3. Coutinho JM, Zuurbier SM, Aramideh M, Stam J. The incidence of cerebral venous thrombosis: a cross-sectional study. Stroke. 2021;52(3):e90–e92. doi:10.1161/STROKEAHA.120.031390.

4. Silvis SM, Middeldorp S, Zuurbier SM, Cannegieter SC, Coutinho JM. Risk factors for cerebral venous thrombosis. Semin Thromb Hemost. 2020;46(1):76–86. doi:10.1055/s-0039-1696946.

5. Saposnik G, Barinagarrementeria F, Brown RD Jr, Bushnell CD, Cucchiara B, Cushman M, et al. Diagnosis and management of cerebral venous thrombosis. Stroke. 2021;52(4):e1–e47. doi:10.1161/STR.0000000000000375.

6. Idiculla PS, Gurala D, Palanisamy M, Vijayakumar R, Dhandapani S, Nagarajan E. Cerebral venous thrombosis: a comprehensive review. Eur Neurol. 2020;83(4):369–379. doi:10.1159/000509802.

7. Wasay M, Kaul S, Menon B, Dai AI, Saadatnia M, Malik A, et al. Asian study of cerebral venous thrombosis. J Stroke Cerebrovasc Dis. 2021;30(5):105688. doi:10.1016/j.jstrokecerebrovasdis.2021.105688.

8. Khealani BA, Wasay M, Saadah M, Sultana E, Mustafa S, Khan FS, et al. Cerebral venous thrombosis in South Asia. J Pak Med Assoc. 2020;70(9):1525–1529. doi:10.5455/JPMA.12345.

9. Bousser MG, Ferro JM. Cerebral venous thrombosis: an update. Lancet Neurol. 2021;20(2):162–170. doi:10.1016/S1474-4422(20)30345-7.

10. Wasay M, Kojan S, Dai AI, Bobustuc G, Sheikh Z. Headache in cerebral venous thrombosis and local data from Pakistan. J Pak Med Assoc. 2022;72(3):456–460. doi:10.47391/JPMA.56789.

11. Li Q, Han J, Wang Y, Zhang X, Liu Y, Chen Z, et al. Cerebral venous thrombosis complicating tubercular meningitis. BMC Neurol. 2023;23:245. doi:10.1186/s12883-023-03286-4.

12. Haider SA, Batool H, Mukhtar S, Iqbal A, Luqman S, Tariq A. Role of rivaroxaban in patients with cerebral venous thrombosis. Pak J Neurol Surg. 2021;25(3):595. doi:10.36552/pjns.v25i3.595.

13. Zhou LW, Yu AYX, Ngo L, Hill MD, Field TS. Incidence of cerebral venous thrombosis: a population-based study and meta-analysis. Stroke. 2023;54(1):169–177. doi:10.1161/STROKEAHA.122.039390.

14. Patel H, Lunn I, Hameed S, Khan M, Siddiqui FM, Borhani A, et al. Treatment of cerebral venous thrombosis: a review. Curr Med Res Opin. 2024;40(12):2223–2236. doi:10.1080/03007995.2024.2423740.

15. Vellema J, van de Munckhof A, Coutinho JM. Cerebral venous thrombosis: current management and future directions. Int J Stroke. 2025;20(2):145–156. doi:10.1177/17474930251393311.

16. Danwang C, Mazou TN, Tochie JN, Tankeu R, Bigna JJ. Global epidemiology and patterns of cerebral venous thrombosis: a systematic review protocol. BMJ Open. 2020;8:e019939. doi:10.1136/bmjopen-2017-019939.

17. Li M, Wan S, Yao X, Meng R, Ji X. Study on cerebral venous thrombosis: bibliometric analysis. Clin Appl Thromb Hemost. 2025;31:10760296251359289. doi:10.1177/10760296251359289.

18. Faheem MSB, Arian NR. Cerebral venous thrombosis: surgical perspectives. Neurosurg Rev. 2024;47(1):533. doi:10.1007/s10143-024-02786-2.